342 related articles for article (PubMed ID: 22978689)
1. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
Qing X; Furong W; Yunxia L; Jian Z; Xuping W; Ling G
Cardiovasc Diabetol; 2012 Sep; 11():108. PubMed ID: 22978689
[TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C levels are associated with coronary artery disease and its severity.
Wang GN; Sun K; Hu DL; Wu HH; Wang XZ; Zhang JS
Clin Biochem; 2014 Nov; 47(16-17):176-81. PubMed ID: 25084128
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum cystatin-c and coronary lesion severity in coronary artery disease patients with a normal glomerular filtration rate.
Pan J; Sun X; Zhang P; Chen H; Lin J
J Int Med Res; 2021 Jan; 49(1):300060520985639. PubMed ID: 33435768
[TBL] [Abstract][Full Text] [Related]
4. Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome.
Zhang J; Wu X; Gao P; Yan P
BMC Cardiovasc Disord; 2017 Jan; 17(1):47. PubMed ID: 28143410
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of serum cystatin C in predicting coronary artery disease.
Koc M; Batur MK; Karaarslan O; Abali G
Cardiol J; 2010; 17(4):374-80. PubMed ID: 20690093
[TBL] [Abstract][Full Text] [Related]
6. Association of Metabolic Syndrome with Chronic Kidney Disease in Elderly Japanese Women: Comparison by Estimation of Glomerular Filtration Rate from Creatinine, Cystatin C, and Both.
Kurata M; Tsuboi A; Takeuchi M; Fukuo K; Kazumi T
Metab Syndr Relat Disord; 2016 Feb; 14(1):40-5. PubMed ID: 26535975
[TBL] [Abstract][Full Text] [Related]
7. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of serum cystatin C in predicting coronary artery disease in patients without chronic kidney disease.
Dandana A; Gammoudi I; Chalghoum A; Chahed H; Addad F; Ferchichi S; Miled A
J Clin Lab Anal; 2014 May; 28(3):191-7. PubMed ID: 24478035
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function.
Wang S; Liu Q; Guo F; Zhou X; Shi J; Xie Q
BMC Cardiovasc Disord; 2020 Apr; 20(1):183. PubMed ID: 32306911
[TBL] [Abstract][Full Text] [Related]
11. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
12. Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population.
Won KB; Chang HJ; Sung J; Shin S; Cho IJ; Shim CY; Hong GR; Kim YJ; Choi BW; Chung N
BMC Cardiovasc Disord; 2014 Aug; 14():105. PubMed ID: 25138993
[TBL] [Abstract][Full Text] [Related]
13. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease.
Kiyosue A; Hirata Y; Ando J; Fujita H; Morita T; Takahashi M; Nagata D; Kohro T; Imai Y; Nagai R
Circ J; 2010 Nov; 74(11):2441-7. PubMed ID: 20921817
[TBL] [Abstract][Full Text] [Related]
14. Serum cystatin C and neutrophil gelatinase-associated lipocalin in predicting the severity of coronary artery disease in diabetic patients.
Okyay K; Yıldırır A; Çiçek M; Aydınalp A; Müderrisoğlu H
Anatol J Cardiol; 2016 Oct; 16(10):756-761. PubMed ID: 27182610
[TBL] [Abstract][Full Text] [Related]
15. Higher serum level of Cystatin C: An additional risk factor of CAD.
Chen Z; Zhang J; Feng J; Zhou G; Jin X; Pan J
Medicine (Baltimore); 2021 Jan; 100(2):e24269. PubMed ID: 33466214
[TBL] [Abstract][Full Text] [Related]
16. Association and predictive value analysis for metabolic syndrome on systolic and diastolic heart failure in high-risk patients.
Tang ZH; Wang L; Zeng F; Zhang K
BMC Cardiovasc Disord; 2014 Sep; 14():124. PubMed ID: 25249273
[TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.
Nardin M; Verdoia M; Barbieri L; De Luca G;
Platelets; 2019; 30(5):615-623. PubMed ID: 30047817
[TBL] [Abstract][Full Text] [Related]
18. Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.
Shen Y; Ding FH; Zhang RY; Zhang Q; Lu L; Shen WF
PLoS One; 2015; 10(9):e0137253. PubMed ID: 26402227
[TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
[TBL] [Abstract][Full Text] [Related]
20. Relationship of cystatin C with coronary artery disease and its severity.
Doganer YC; Aydogan U; Aydogdu A; Aparci M; Akbulut H; Nerkiz P; Turker T; Cayci T; Barcin C; Saglam K
Coron Artery Dis; 2013 Mar; 24(2):119-26. PubMed ID: 23211477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
